Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade)

Kura Oncology, Inc. (NASDAQ: KURA ) is a clinically staged biopharma, established in 2014 and headquartered in San Diego, California. The company focuses exclusively on the development of small-molecule drugs that are informed by patient selection biomarkers, also known asBrendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) ...